The 2026 E/M Shift: What Podiatrists Need to Know Now
As we navigate through 2026, the medical billing landscape for podiatry has undergone its most significant structural change in years. While the headlines often focus on general healthcare trends, the reality for podiatrists is found in the technical details of the Medicare Physician Fee Schedule (PFS) and the nuances of Evaluation and Management (E/M) coding.
At JARALL, we've seen that the practices thriving this year are the ones that moved beyond "checkbox" documentation. Here is a deep dive into the 2026 E/M shifts and how they impact your bottom line.
1. The Dual Conversion Factor Reality
For the first time, podiatrists are dealing with a statutory split in how they are reimbursed. Based on your participation in Advanced Alternative Payment Models (APMs), you are likely seeing one of two rates:
Qualifying APM Participants (QPs) — Received a 3.77% increase, bringing the conversion factor to approximately $33.57.
Non-QPs (Standard Track) — Received a 3.26% increase, resulting in a rate of approximately $33.40.
While these increases—driven by the "One Big Beautiful Bill" Act—are a win for the industry, they are offset by a new -2.5% "efficiency adjustment" applied to work RVUs for non-time-based services. This means your E/M levels (99202–99215) must be optimized to cover the tightening margins on the procedures that follow them.
2. The Modifier -25 Microscope
In 2026, "unbundling" has become the primary target for Medicare Administrative Contractors (MACs). If you bill an E/M code on the same day as a procedure—such as an injection or nail debridement—you are under a microscope.
The JARALL Standard: Your documentation must prove that the E/M was "separately identifiable." If a patient presents for a scheduled injection but also mentions a new, unrelated sharp pain in the contralateral heel, you have a separate E/M. However, if your note merely describes the pre-operative assessment for the injection, that E/M will be denied or recouped in an audit.
3. Remote Physiologic Monitoring (RPM) Breakthroughs
2026 has brought a massive shift in how podiatrists can bill for remote care. Previously, you needed 16 days of data to bill for device supply. The new 2026 guidelines allow for billing CPT 99445 (Remote monitoring) with as little as 2–15 days of data in a 30-day period.
For podiatrists managing chronic wounds or postoperative recovery via smart dressings or temperature-monitoring insoles, this opens a massive new revenue stream that was previously barred by "administrative red tape."
How JARALL Protects You
At JARALL, we don't just "process" your claims; we audit your clinical logic. Our 2026 workflow includes:
E/M Level Validation — Ensuring your Medical Decision Making (MDM) actually supports a 99214 before it's sent.
Modifier Integrity — Cross-referencing procedure codes with E/M notes to ensure Modifier -25 is defensible.
Tech-Forward Billing — Integrating the new RPM codes into your revenue cycle to capture every dollar of remote care.